Publicação: Comparison of impurity profiles of lipiblock® vs. orlistat using HPLC and LC-MS/MS
Nenhuma Miniatura disponível
Data
2012-04-30
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Acesso restrito
Resumo
Comparative HPLC-UV and LC-MS/MS studies of impurity profiles of a reference sample (Xenical®, F. Hoffmann-La Roche Ltd., Switzerland) vs. generic (Lipiblock®, EMS-Sigma Pharma, a generic drug) were carried out with ethanol extracts of commercial samples. The generic formulation contained higher levels of common impurities as well as a considerable number of impurities not found in the reference product. The detected impurity profile of Lipiblock® revealed that it most likely is based on fermentation. Since the effect of the impurities is unknown, at this point fully synthetic Xenical® appears to offer a better safety margin than Lipiblock® which, however, compares quite well to other generic formulations.
Descrição
Palavras-chave
Generics, HPLC-MS/MS, HPLC-UV, Orlistat, cobese, generic drug, lipiblock, orsoten, rotipuran, suprapur, tetrahydrolipstatin, unclassified drug, controlled study, drug formulation, drug impurity, drug safety, drug structure, fermentation, high performance liquid chromatography, intermethod comparison, liquid chromatography, mass spectrometry
Idioma
Inglês
Como citar
Latin American Journal of Pharmacy, v. 31, n. 1, p. 91-96, 2012.
